Date | Compound | Laboratory | Indication | Type of Information |
---|---|---|---|---|
2017-11-23 | recombinant human nerve growth factor | Dompé (Italy) | neurotrophic keratitis | Product launch |
2014-07-09 | Qiagen (Germany - the Netherlands) | cytomegalovirus (CMV) testing in the management of solid organ transplant patients |
Granting of a Market Authorisation in the US | |
2014-07-09 | PLX-PAD Cells (Placental eXpanded cells) | Pluristem Therapeutics (Israel) | ulcerative colitis Crohn\'s disease |
Granting of a patent |
2018-07-26 | blinatumomab | Amgen (USA - CA) |
|
Positive opinion for the granting of a Market Authorisation in the EU |
2014-07-10 | gene expression test | Diaxonhit (France) CareDx (USA - CA) | identification of heart transplant recipients with stable allograft function who have a low probability of moderate/severe acute cellular rejection (ACR) |
Product launch |
2015-05-26 | fixed-dose combination of tiotropium + olodaterol Respimat® | Boehringer Ingelheim (Germany) | chronic obstructive pulmonary disease (COPD) |
Granting of a Market Authorisation in the US |
2015-07-08 | Summit Therapeutics (UK) | Clostridium difficile infection |
Granting of a Fast Track status | |
0000-00-00 | Plant acquisition | |||
2017-12-13 | pegaspargase - pegylated L-asparaginase | Baxalta (USA - IL) now Shire (UK - USA) | acute lymphoblastic leukaemia (ALL) | Granting of a Market Authorisation in the EU |
2018-10-18 | coagulation factor VIIa | Novo Nordisk (Denmark) |
|
Positive opinion for the granting of a Market Authorisation in the EU |
2014-11-19 | siponimod | dermatomyositis |
Granting of the orphan status in the EU | |
2014-07-16 | maytansinoid conjugated humanized monoclonal antibody against FOLRI | Immunogen (USA - MA) | ovarian cancer |
Granting of the orphan status in the USA |
2014-04-14 | volasertib | Boehringer Ingelheim (Germany) | acute myeloid leukemia (AML) |
Granting of the orphan status in the US |
2014-07-16 | samidorphan and olanzapine | Alkermes (Ireland) | schizophrenia |
Granting of a patent |
2014-07-16 | ALKS 7106 | Alkermes (Ireland) | pain |
Granting of a patent |
2015-01-16 | apremilast | Celgene (USA - NJ) | active psoriatic arthritis (PsA) |
Granting of a Market Authorisation in the EU |
2014-07-17 | microwave-based ablation system | Covidien (Ireland) | use in percutaneous, laparoscopic and intraoperative coagulation (ablation) of soft tissue, including partial or complete ablation of non-resectable liver tumors
|
Product launch |
2014-07-19 | midkine and the closely related protein pleiotrophin | Cellmid (Australia) | prevention of hair loss, enhancement of hair growth |
Granting of a patent |
2015-04-08 | bevacizumab | Roche (Switzerland) | persistent, recurrent or metastatic cervical cancer | Granting of a Market Authorisation in the EU |
2014-07-20 | long-acting version of clotting Factor VIIa | OPKO Health (USA) | treatment of bleeding episodes in patients with hemophilia A or B with inhibitors to Factor VIII or Factor IX and congenital Factor VII deficiency |
Positive opinion for the granting of the orphan status in the EU |
© 2024 Biopharmanalyses - Powered by Samacom+